6533b832fe1ef96bd129ac19
RESEARCH PRODUCT
Immunotherapy is not for all comers in chemotherapy-refractory advanced gastric cancer. Better predictive biomarkers are needed
Elizabeth C SmythAndrés Cervantessubject
0301 basic medicineOncologyChemotherapymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentMEDLINEHematologyImmunotherapyAdvanced gastric cancer03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyRefractory030220 oncology & carcinogenesisInternal medicineMonoclonalmedicineEsophagogastric junctionbusinessPredictive biomarkeryear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |